Tclin PDE3A cGMP-inhibited 3',5'-cyclic phosphodiesterase A

Protein Summary

Description

Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes. This gene encodes a member of the cGMP-inhibited cyclic nucleotide phosphodiesterase (cGI-PDE) family. cGI-PDE enzymes hydrolyze both cAMP and cGMP, and play critical roles in many cellular processes by regulating the amplitude and duration of intracellular cyclic nucleotide signals. The encoded protein mediates platelet aggregation and also plays important roles in cardiovascular function by regulating vascular smooth muscle contraction and relaxation. Inhibitors of the encoded protein may be effective in treating congestive heart failure. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Sep 2011]

Uniprot Accession IDs

• Q14432
• O60865
• Q13348
• Q17RD1

Gene Name

• PDE3A

Ensembl ID

• ENST00000359062
• ENSP00000351957
• ENSG00000172572

Symbol

• HTNB
• CGI-PDE
• CGI-PDE A
• CGI-PDE-A

Knowledge Table

Most Knowledge About	Knowledge Value (0 to 1 scale)
biological process	0.9
molecular function	0.9
ligand (protein) perturbation	0.83
histone modification site profile	0.72
gene perturbation	0.66

Protein Classes

No PANTHER Classes or DTO Classes found

IDG Development Level Summary

Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 199.31   (req: < 5)

Gene RIFs: 42   (req: <= 3)

Antibodies: 210   (req: <= 50)

Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 199.31   (req: >= 5)

Gene RIFs: 42   (req: > 3)

Antibodies: 210   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 18

Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligands: 160

Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drugs: 11